Vasopressin amplifies the production of proinflammatory mediators in traumatic brain injury

Journal of Neurotrauma

Volumn 27, Issue 8, 2010, Pages 1449-1461

  Szmydynger Chodobska, Joanna ^a   Fox, Leora M ^a   Lynch, Kirsten M ^a   Zink, Brian J ^a   Chodobski, Adam ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

arginine vasopressin; c Jun N terminal kinase; CXC and CC chemokines; monocytes; neutrophils; traumatic brain injury

Indexed keywords

ALPHA CHEMOKINE; ARGIPRESSIN; BETA CHEMOKINE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRATTLEBORO RAT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM; ENZYME ACTIVITY; LONG EVANS RAT; MALE; NONHUMAN; RAT; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN; BRAIN INJURIES; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CXCL1; CHEMOKINE CXCL2; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INFLAMMATION MEDIATORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; RATS; RATS, BRATTLEBORO; RATS, LONG-EVANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; VASOPRESSINS;

EID: 77955893200     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2010.1331     Document Type: Article

References (44)

1. Barreca, T., Gandolfo, C., Corsini, G., Del Sette, M., Cataldi, A., Rolandi, E., and Franceschini, R. (2001). Evaluation of the secretory pattern of plasma arginine vasopressin in stroke patients. Cerebrovasc. Dis. 11, 113-118. (Pubitemid 32171170)
2. Beech, J.S., Reckless, J., Mosedale, D.E., Grainger, D.J., Williams, S.C., and Menon, D.K. (2001). Neuroprotection in ischemiareperfusion injury: an antiinflammatory approach using a novel broad-spectrum chemokine inhibitor. J. Cereb. Blood Flow Metab. 21, 683-689.
3. Bell, M.D., Taub, D.D., Kunkel, S.J., Strieter, R.M., Foley, R., Gauldie, J., and Perry, V.H. (1996). Recombinant human adenovirus with rat MIP-2 gene insertion causes prolonged PMN recruitment to the murine brain. Eur. J. Neurosci. 8, 1803-1811.
4. Bemana, I., and Nagao, S. (1999). Treatment of brain edema with a nonpeptide arginine vasopressin V1 receptor antagonist OPC-21268 in rats. Neurosurgery 44, 148-154.
5. Chang, Y., Chen, T.Y., Chen, C.H., Crain, B.J., Toung, T.J., and Bhardwaj, A. (2006). Plasma arginine-vasopressin following experimental stroke: effect of osmotherapy. J. Appl. Physiol. 100, 1445-1451.
6. Chen, Y., Hallenbeck, J.M., Ruetzler, C., Bol, D., Thomas, K., Berman, N.E., and Vogel, S.N. (2003). Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J. Cereb. Blood Flow Metab. 23, 748-755.
7. Cunningham, L.A., Wetzel, M., and Rosenberg, G.A. (2005). Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50, 329-339.
8. DePasquale, M., Patlak, C.S., and Cserr, H.F. (1989). Brain ion and volume regulation during acute hypernatremia in Brattleboro rats. Am. J. Physiol. 256, F1059-F1066.
9. Dickinson, L.D., and Betz, A.L. (1992). Attenuated development of ischemic brain edema in vasopressin-deficient rats. J. Cereb. Blood Flow Metab. 12, 681-690.
10. Dimitrijevic, O.B., Stamatovic, S.M., Keep, R.F., and Andjelkovic, A.V. (2007). Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 38, 1345-1353.
11. Garberg, P., Ball, M., Borg, N., Cecchelli, R., Fenart, L., Hurst, R.D., Lindmark, T., Mabondzo, A., Nilsson, J.E., Raub, T.J., Stanimirovic, D., Terasaki, T., Öberg, J.O., and Österberg, T. (2005). In vitro models for the blood-brain barrier. Toxicol. In Vitro 19, 299-334.
12. Hanazawa, S., Takeshita, A., Amano, S., Semba, T., Nirazuka, T., Katoh, H., and Kitano, S. (1993). Tumor necrosis factor-a induces expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268, 9526-9532.
13. Hirasawa, A., Hashimoto, K., and Tsujimoto, G. (1994). Distribution and developmental change of vasopressin V1A and V2 receptor mRNA in rats. Eur. J. Pharmacol. 267, 71-75.
14. Kim, D.S., Han, J.H., and Kwon, H.J. (2003). NF-kB and c-Jundependent regulation of macrophage inflammatory protein-2 gene expression in response to lipopolysaccharide in RAW 264.7 cells. Mol. Immunol. 40, 633-643.
15. Kuschert, G.S., Coulin, F., Power, C.A., Proudfoot, A.E., Hubbard, R.E., Hoogewerf, A.J., and Wells, T.N. (1999). Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38, 12959-12968.
16. Liu, X., Jin, Y., Zheng, H., Chen, G., Tan, B., and Wu, B. (2000). Arginine vasopressin gene expression in supraoptic nucleus and paraventricular nucleus of hypothalamus following cerebral ischemia and reperfusion. Chin. Med. Sci. J. 15, 157-161.
17. Longhi, L., Perego, C., Ortolano, F., Zanier, E.R., Bianchi, P., Stocchetti, N., McIntosh, T.K., and De Simoni, M.G. (2009). C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice. Crit. Care Med. 37, 659-665.
18. Mather, H.M., Ang, V., and Jenkins, J.S. (1981). Vasopressin in plasma and CSF of patients with subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry 44, 216-219.
19. Nagao, M., Yamauchi, J., Kaziro, Y., and Itoh, H. (1998). Involvement of protein kinase C and Src family tyrosine kinase in Gaq/11-induced activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. J. Biol. Chem. 273, 22892-22898.
20. Neumann, J., Sauerzweig, S., RÖnicke, R., Gunzer, F., Dinkel, K., Ullrich, O., Gunzer, M., and Reymann, K.G. (2008). Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of CNS immune privilege. J. Neurosci. 28, 5965-5975.
21. Ostrowski, N.L., Lolait, S.J., and Young, W.S., III (1994). Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature. Endocrinology 135, 1511-1528.
22. Pascale, C.L., Szmydynger-Chodobska, J., Sarri, J.E., and Chodobski, A. (2006). Traumatic brain injury results in a concomitant increase in neocortical expression of vasopressin and its V1A receptor. J. Physiol. Pharmacol. 57 Suppl. 11, 161-167.
23. Rosenberg, G.A., Cunningham, L.A., Wallace, J., Alexander, S., Estrada, E.Y., Grossetete, M., Razhagi, A., Miller, K., and Gearing, A. (2001). Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res. 893, 104-112.
24. Rosenberg, G.A., Scremin, O., Estrada, E., and Kyner, W.T. (1992). Arginine vasopressin V1-antagonist and atrial natriuretic peptide reduce hemorrhagic brain edema in rats. Stroke 23, 1767-1773.
25. Sato, H., and Seiki, M. (1993). Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8, 395-405.
26. Schmale, H., and Richter, D. (1984). Single base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats. Nature 308, 705-709.
27. Schoettle, R.J., Kochanek, P.M., Magargee, M.J., Uhl, M.W., and Nemoto, E.M. (1990). Early polymorphonuclear leukocyte accumulation correlates with the development of posttraumatic cerebral edema in rats. J. Neurotrauma 7, 207-217.
28. Shohami, E., Ginis, I., and Hallenbeck, J.M. (1999). Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev. 10, 119-130.
29. Shuaib, A., Xu Wang, C., Yang, T., and Noor, R. (2002). Effects of nonpeptide V1 vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model. Stroke 33, 3033-3037.
30. Sørensen, P.S., Gjerris, F., and Hammer, M. (1985). Cerebrospinal fluid vasopressin in neurological and psychiatric disorders. J. Neurol. Neurosurg. Psychiatry 48, 50-57. (Pubitemid 15080591)
31. Stamatovic, S.M., Shakui, P., Keep, R.F., Moore, B.B., Kunkel, S.L., Van Rooijen, N., and Andjelkovic, A.V. (2005). Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J. Cereb. Blood Flow Metab. 25, 593-606.
32. Szmydynger-Chodobska, J., Chung, I., Koźniewska, E., Tran, B., Harrington, F.J., Duncan, J.A., and Chodobski, A. (2004). Increased expression of vasopressin V1a receptors after traumatic brain injury. J. Neurotrauma 21, 1090-1102.
33. Szmydynger-Chodobska, J., Strazielle, N., Zink, B.J., Ghersi-Egea, J.F., and Chodobski, A. (2009). The role of the choroid plexus in neutrophil invasion after traumatic brain injury. J. Cereb. Blood Flow Metab. 29, 1503-1516.
34. Taupin, V., Toulmond, S., Serrano, A., Benavides, J., and Zavala, F. (1993). Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type ( p site) benzodiazepine ligand. J. Neuroimmunol. 42, 177-185.
35. Trabold, R., Krieg, S., Scholler, K., and Plesnila, N. (2008). Role of vasopressin V1a and V2 receptors for the development of secondary brain damage after traumatic brain injury in mice. J. Neurotrauma 25, 1459-1465.
36. Vakili, A., Kataoka, H., and Plesnila, N. (2005). Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 25, 1012-1019.
37. Waetzig, V., and Herdegen, T. (2005). Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. Trends Pharmacol. Sci. 26, 455-461.
38. Wang, X., Jung, J., Asahi, M., Chwang, W., Russo, L., Moskowitz, M.A., Dixon, C.E., Fini, M.E., and Lo, E.H. (2000). Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J. Neurosci. 20, 7037-7042.
39. Wang, Y., Luo, W., Stricker, R., and Reiser, G. (2006). Proteaseactivated receptor-1 protects rat astrocytes from apoptotic cell death via JNK-mediated release of the chemokine GRO/ CINC-1. J. Neurochem. 98, 1046-1060.
40. Xu, M., Su, W., Huang, W.D., Lu, Y.Q., Xu, Q.P., and Chen, Z.J. (2007). Effect of AVP on brain edema following traumatic brain injury. Chin. J. Traumatol. 10, 90-93.
41. Yamasaki, Y., Matsuo, Y., Zagorski, J., Matsuura, N., Onodera, H., Itoyama, Y., and Kogure, K. (1997). New therapeutic possibility of blocking cytokine-induced neutrophil chemoattractant on transient ischemic brain damage in rats. Brain Res. 759, 103-111.
42. Yang, K., Mu, X.S., Xue, J.J., Whitson, J., Salminen, A., Dixon, C.E., Liu, P.K., and Hayes, R.L. (1994). Increased expression of c-fos mRNA and AP-1 transcription factors after cortical impact injury in rats. Brain Res. 664, 141-147. (Pubitemid 2161794)
43. Yoshida, M., Iwasaki, Y., Asai, M., Takayasu, S., Taguchi, T., Itoi, K., Hashimoto, K., and Oiso, Y. (2006). Identification of a functional AP1 element in the rat vasopressin gene promoter. Endocrinology 147, 2850-2863.
44. Young, L.J., Toloczko, D., and Insel, T.R. (1999). Localization of vasopressin (V1a) receptor binding and mRNA in the rhesus monkey brain. J. Neuroendocrinol. 11, 291-297.